Neurologia wydarzenia
Minimizing Risks and Maximizing Efficacy for Management...
Multiple sclerosis (MS) affects nearly 400,000 people in the United States and over 2.5 million people worldwide. Diagnostic methods and treatment plans developed...
Optimizing the Risk-Benefit Therapeutic Equation for...
Neurologic specialists and their patients understand that multiple sclerosis (MS) is a lifelong, immune-mediated progressive disorder. The early age of onset...
Wielospecjalistyczny Kurs Medycyny Manualnej
W imieniu Rady Naukowej oraz Organizatora zapraszamy na kolejną już edycję Wielospecjalistycznego Kursu Medycyny Manualnej, która rozpocznie się w dniach...
12th Annual Pediatric Neuroscience Update
This course is designed for practitioners who are respon- sible for treating children with neurological, neurodevel- opmental, and neurobehavioral disorders....
Minimizing Risks and Maximizing Efficacy for Management...
Multiple sclerosis (MS) affects nearly 400,000 people in the United States and over 2.5 million people worldwide. Diagnostic methods and treatment plans developed...
Optimizing the Risk-Benefit Therapeutic Equation for...
Neurologic specialists and their patients understand that multiple sclerosis (MS) is a lifelong, immune-mediated progressive disorder. The early age of onset...
Neurology/Psychiatry for Primary Care
Upon completion of this program, participants should be better able to: - Review a neurological exam - Explain the differential diagnosis of seizures and...
Minimizing Risks and Maximizing Efficacy for Management...
Multiple sclerosis (MS) affects nearly 400,000 people in the United States and over 2.5 million people worldwide. Diagnostic methods and treatment plans developed...
Optimizing the Risk-Benefit Therapeutic Equation for...
Neurologic specialists and their patients understand that multiple sclerosis (MS) is a lifelong, immune-mediated progressive disorder. The early age of onset...
Neurologia 2013 - IX Krajowa Konferencja Szkoleniowa...
Koleżanki i Koledzy Neurolodzy, Tematem przewodnim najbliższej konferencji naukowo-szkoleniowej organizowanej, tradycyjnie na początku marca, pod patronatem redakcji...
Konferencja „Zaburzenia neurorozwojowe–wspólny obszar...
W dniach 8-9 marca 2013 roku we Warszawie odbędzie się konferencja ,,Zaburzenia neurorozwojowe – wspólny obszar psychiatrii dorosłych i psychiatrii dziecięco-młodzieżowej”....
Minimizing Risks and Maximizing Efficacy for Management...
Multiple sclerosis (MS) affects nearly 400,000 people in the United States and over 2.5 million people worldwide. Diagnostic methods and treatment plans developed...
Optimizing the Risk-Benefit Therapeutic Equation for...
Neurologic specialists and their patients understand that multiple sclerosis (MS) is a lifelong, immune-mediated progressive disorder. The early age of onset...
Minimizing Risks and Maximizing Efficacy for Management...
Multiple sclerosis (MS) affects nearly 400,000 people in the United States and over 2.5 million people worldwide. Diagnostic methods and treatment plans developed...
Optimizing the Risk-Benefit Therapeutic Equation for...
Neurologic specialists and their patients understand that multiple sclerosis (MS) is a lifelong, immune-mediated progressive disorder. The early age of onset...
Użytkownicy
Kanały
-
UCD Medicine
instytucja medyczna
-
High Impact
instytucja medyczna
-
Alila Medical Media
instytucja medyczna
-
Dr Najeeb
instytucja medyczna
-
Neurologic Exam Videos
instytucja medyczna